PharmaReports: Oncology
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
All reports focusing on oncology are featured here with the exception of antibody, immunological or cell therapeutic approaches which are listed on the Cancer Immunotherapy channel.
Showing results 51 - 100 of 225
- Chronic Leukemias - Curative Intent Raises the Bar
- Innovative Targeted Oncology Therapies
- Optimizing Targeted Treatment in Cancer: Negotiating the Challenges to Success
- Commercial Insight: Cytotoxics - Generic Adversity Facing Major Cytotoxics
- Commercial Insight: Antihormonal Therapies Aromatase Inhibitors Reinvigorate a Mature Market
- Stakeholder Opinions: Primary Brain Cancer
- Pipeline Insight: Hematological malignancies - Targeted treatments & immunotherapy
- Monoclonal Antibody Therapies: Evolving into a $30 billion market
- Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer
- Pipeline Insight: Cancer Vaccines and Cell Therapies
- Head and Neck Cancer - Innovatives to Change the Face of Treatment
- Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
- Spectrum Pharmaceuticals' Oral Satraplatin
- Cancer Biomarkers: Enhancing diagnostic, therapeutic and developmental strategies
- Non-Small Cell Lung Cancer - Angiogenesis and signal transduction inhibitors to expand market
- Hepatocellular Carcinoma - Opportune indication for novel therapies
- Supportive Care in Oncology-Significant growth opportunities in new supportive care indications
- Cell-Based Assays for Drug Discovery
- Stakeholder Opinions: Primary Brain Cancer
- Personalized Medicine
- Colorectal Cancer Drug Pipeline Update 2007
- Stakeholder Opinions: Primary Brain Cancer
- Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted therapies
- Melanoma Therapeutics: Which Strategy Will Take Us There?
- Apoptosis: Promise or deception?
- Breast Cancer Drug Pipeline Update 2007
- Breast Cancer - Therapeutic And Competitive Insights
- Angiogenesis in Oncology: Drug Pipeline Update 2007
- Immunotherapy in Oncology: Gaining Momentum
- MYELODYSPLASTIC SYNDROME - Therapy Area Pipeline Report
- LEUKEMIA - Therapy Area Pipeline Report
- BREAST CANCER - Therapy Area Pipeline Report
- GASTRIC CANCER - Therapy Area Pipeline Report
- HEAD AND NECK CANCER - Therapy Area Pipeline Report
- KIDNEY CANCER - Therapy Area Pipeline Report
- LIVER CANCER - Therapy Area Pipeline Report
- MELANOMA and SKIN CANCER - Therapy Area Pipeline Report
- MULTIPLE MYELOMA - Therapy Area Pipeline Report
- NON - HODGKIN LYMPHOMA (NHL) - Therapy Area Pipeline Report
- OVARIAN CANCER - Therapy Area Pipeline Report
- PANCREATIC CANCER - Therapy Area Pipeline Report
- PROSTATE CANCER - Therapy Area Pipeline Report
- NAUSEA AND VOMITING - Therapy Area Pipeline Report
- Innovative and Targeted Cancer Therapies: Key technologies, new applications and leading players
- Decoding Big Pharmas R&D Strategy in Oncology
- Treating Neuropathic Pain: A Global Study of Clinical Strategies
- Monoclonal Antibodies: strategic analysis of the mAb market out to 2012
- Pipeline Insight: Cancer Overview - Increasing diversity offers both high risk and reward
- Biomarker Technology Platforms for Cancer Diagnoses and Therapies
- Global Smoking Cessation Market Analysis & Forecasts - Preparing for the First Blockbuster
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development